APA (7th ed.) Citation

Hideki Maeda, Ayano Okabe, Kenichi Sakakura, Daniel Bin Ng, & Manabu Akazawa. (2021). Relationships between developmental strategies for additional indications and price revisions for anticancer drugs in Japan. BMC.

Chicago Style (17th ed.) Citation

Hideki Maeda, Ayano Okabe, Kenichi Sakakura, Daniel Bin Ng, and Manabu Akazawa. Relationships Between Developmental Strategies for Additional Indications and Price Revisions for Anticancer Drugs in Japan. BMC, 2021.

MLA (9th ed.) Citation

Hideki Maeda, et al. Relationships Between Developmental Strategies for Additional Indications and Price Revisions for Anticancer Drugs in Japan. BMC, 2021.